COVID-19 Viral Testing
Slow The Spread With Viral Testing
If you think you’ve been infected with COVID-19 or have recently come in contact with someone who has tested positive for COVID-19, then viral testing can help you make an informed decision about returning to work or school, traveling, or self-isolating to help slow the spread.
The Rapid (Antigen) and Standard (PCR) viral tests are a nasal/throat swab that are designed to identify current infections of the COVID-19 virus.
Rapid Viral Testing (PCR)
The Rapid (PCR) viral test uses a nasal/throat swab to detect a current infection of COVID-19 in your body. Best used at least 48 hours after exposure, and can provide results in just a few hours. This test may be required before certain surgeries, returning to work, and traveling to certain countries. *However, several countries do not accept this rapid format rt-PCR. Always check with the embassy of the country you’re traveling to before scheduling your test.
FIND YOUR LOCATION
Standard (PCR) Viral Testing
The Standard (PCR) viral test uses a nasal/throat swab to detect a current infection of COVID-19 in your body. This test may be required before certain surgeries, returning to work, discontinuing self-isolation, and even traveling to certain countries.
FIND YOUR LOCATION
Comparing the Viral COVID-19 Testing Options
Testing is Simple And Quick
Step 1Schedule your appointment
Step 2Go to your local ARCpoint Labs and get your sample collected
Step 3Get results via a secure email in a timely manner
Want to know more about COVID-19 Test Options?
Get the answers to some of the most asked questions in our COVID-19 FAQs.View Our FAQs
* Important Information
Please note that our tests have not been FDA cleared or approved, but they have been authorized by FDA under Emergency Use Authorizations (EUA’s) for use by authorized laboratories. Depending on the specific test type, these tests are authorized for the detection of SARS CoV-2, its proteins and/or its antibodies. These tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
Please click below to see the specific FDA disclaimers and additional manufacturer information for each test and device used by ARCpoint or our laboratory partners.
COVID Testing Disclaimers